Shares of Glenmark Pharmaceuticals Ltd ended at ₹2,238.50, up by ₹47.45, or 2.17%, on the BSE. Previous Post Powerica locks in 25-year power purchase deal for 100 MW Gujarat wind project Next Post Aarti Drugs Q1 profit falls 7% despite 19% revenue growth; announces leadership transition Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
